The Regulatory Review

The Benefits of Public Advisory Committees at the FDA

The Benefits of Public Advisory Committees at the FDA

More committees with less conflicted members may increase regulatory safety.

Regulatory Opinion: Year in Review

Regulatory Opinion: Year in Review

We feature our top opinion posts from 2012.

Regulatory Analysis: Year in Review

Regulatory Analysis: Year in Review

We feature our top analysis essays from 2012.

Regulatory News: Year in Review

Regulatory News: Year in Review

We feature our top news posts from 2012.

Week in Review

Week in Review

CFPB signs data deal with DOJ, EU opposes Internet regulation, and more.

Week in Review

Week in Review

EPA suspends BP from new federal contracts, SEC Chairman to step down, and more.

Week in Review

Week in Review

HHS proposes insurance market regulations, New York delays decision on fracking regulation, and more.

Regulating the Cranberry

Regulating the Cranberry

Thanksgiving staple faces a surprisingly complex web of regulations.

Week in Review

Week in Review

British Petroleum agrees to billion-dollar oil spill settlement, FDA asks for legislation on compounding pharmacies, and more.

Week in Review

Week in Review

Colorado passes marijuana proposition, Californians reject GMO labeling regulation, and more.

Week in Review

Week in Review

Hurricane Sandy triggers responses by federal and state agencies, a federal judge curtails contraception mandate, and more.

Week in Review

Week in Review

FDA investigates energy drink following deaths, CFPB expands supervision of credit reporting, and more.